- Kick-start for metabolomics in liver disease
- Browse: 399 Download: 830 Issue Date: 2024-09-23
- Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
- Browse: 313 Download: 883 Issue Date: 2024-08-22
- Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
- Browse: 432 Download: 1000 Issue Date: 2024-08-22
- Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
- Browse: 408 Download: 825 Issue Date: 2024-08-22
- Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
- Browse: 384 Download: 682 Issue Date: 2024-08-22
- Rocahepevirus ratti: An underrecognised cause of acute hepatitis
- Browse: 301 Download: 685 Issue Date: 2024-08-22
- Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
- Browse: 561 Download: 1103 Issue Date: 2024-07-26
- Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
- Browse: 459 Download: 1335 Issue Date: 2024-07-26
- Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
- Browse: 534 Download: 960 Issue Date: 2024-07-26
- Interleukin-mediated therapies in liver diseases and comorbidity effects
- Browse: 433 Download: 987 Issue Date: 2024-07-26
- Roles of transforming growth factor-β signaling in liver disease
- Browse: 475 Download: 1031 Issue Date: 2024-07-26
- Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
- Browse: 497 Download: 1007 Issue Date: 2024-06-27
- Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
- Browse: 436 Download: 1268 Issue Date: 2024-06-27
- Importance of the gut microbiota in the gut-liver axis in normal and liver disease
- Browse: 426 Download: 756 Issue Date: 2024-06-27
- Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
- Browse: 346 Download: 716 Issue Date: 2024-06-27
- Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis
- Browse: 389 Download: 774 Issue Date: 2024-06-27
- Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease
- Browse: 467 Download: 1401 Issue Date: 2024-05-27
- Current concepts in the management of non-cirrhotic non-malignant portal vein thrombosis
- Browse: 492 Download: 1088 Issue Date: 2024-05-27
- Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?
- Browse: 412 Download: 802 Issue Date: 2024-05-27
- Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease
- Browse: 349 Download: 866 Issue Date: 2024-05-27